Diabetic foot ulcer & chronic wounds: TOP – N53
significantly improving microcirculation and fosters angiogenesis at the wound tissue
Scar & keloid prevention: TOP – N44
providing anti-inflammatory and anti-fibrotic effects
Topadur’s lead R&D proprietary programs are local active, highly potent, dual mode of action drugs. Topadur’s unique development candidates work on validated drug targets resulting in higher than average clinical success chances.